ClinicalTrials.gg
Drug

Inebilizumab clinical trials

Also written MEDI-551 and UPLIZNA.

studies test it
24
open now
11
in phase 3
6
first study started
2010

How each study uses inebilizumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the inebilizumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
11 Jun 2020 · UPLIZNA · BLA 761142 (FDA, Drugs@FDA)
European Union
25 Apr 2022 · Uplizna · EMEA/H/C/005818 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Inebilizumab
18

Brand

UPLIZNA
3

Development codes

MEDI-551
6
VIB0551
1
MT-0551
1
AMG 335
1

Studies by the year they started

24 studies that test it; most in 2026 (6)

Studies that test inebilizumab, by start year
YearStudies
20102
20111
20123
20151
20171
20191
20202
20222
20231
20242
20252
20266

Who runs them

Industry 19 · Other 5

Amgen (10) · MedImmune LLC (6) · Tanabe Pharma Corporation (1) · AstraZeneca (1) · Charite University, Berlin, Germany (1) · Hansoh BioMedical R&D Company (1) · Ruijin Hospital (1) · Massachusetts General Hospital (1)

Often tested with

Tested in the same studies.

Blinatumomab (1) · Eculizumab (1) · Ravulizumab (1) · Satralizumab (1) · Dazodalibep (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test inebilizumab.

Studies

Open first, then newest update. How each study uses inebilizumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 24

See all 24 studies that test inebilizumab →

Given beside what is tested · 1 — inebilizumab is usual care or a partner of the new treatment

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call inebilizumab · ClinicalTrials.gg INT000514

  • MeSH (NLM) C000609745inebilizumabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 74T7185BMMINEBILIZUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 2373951One source FDA
  • Wikidata Q25326696InebilizumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C88283InebilizumabOne source FDA
  • DrugBank DB12530One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.